top of page
Friday, June 11, 2021
SESSION 1: New Perspectives on HBV Virology
SESSION 2: Evaluation of HBV Infected Patients: Current Practice and New Horizons
SESSION 3: New Perspectives on HBV Virology
SESSION 4: Controversies in Current Therapy
SESSION 5: Controversies in Current Therapy
Saturday, June 11, 2021
SESSION 6: Immune-Based Therapies
SESSION 7: HBV Drug Development – General Considerations
SESSION 8: Hepatitis D
SESSION 9: Advocacy
bottom of page